Antibiotic-free Helicobacter pylori eradication – case reports and review of the literature

Author:

Bahadori Babak1ORCID,Tonninger-Bahadori Katayoun2,Nekrep Karl3

Affiliation:

1. Office for Internal Medicine, Gastroenterology, and Hepatology

2. Office for general and visceral surgery

3. Private biologist office

Abstract

Abstract Background: Standard Helicobacter pylori eradication therapy is based on proton pump inhibitors and antibiotics. There are, however, important limitations: increasing antibiotic resistance of Helicobacter pylori, medical contraindications, and an increasing unwillingness among patients to use antibiotics. Case presentations: We present three exemplary case reports of successful antibiotic-free Helicobacter pylorieradication therapies, one for each of these limiting categories: a 61-year-old female Caucasian patient refractory to prior eradication therapy, an 80-year-old female Caucasian patient with contraindication to antibiotics, and a 41-year-old male Caucasian patient refusing antibiotics. A review of the literature attempts to provide a scientific rationale for proton pump inhibitor-based and probiotics-supported Helicobacter pylorieradication. Conclusion: Antibiotics-free Helicobacter pylorieradication may offer a therapeutic option for patients in whom classical eradication therapy cannot be conducted or who are refractory to antibiotics. Clinical trials are needed to scientifically evaluate the concept presented here.

Publisher

Research Square Platform LLC

Reference17 articles.

1. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication;Nyssen OP;Cochrane Database Syst Rev,2016

2. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report;Malfertheiner P;Gut,2017

3. [S2k-guideline Helicobacter pylori and gastroduodenal ulcer disease];Fischbach W;Z für Gastroenterologie,2016

4. Bundesamt für Sicherheit im Gesundheitswesen. : Summary of product characteristics: Pylera. https://aspregister.basg.gv.at/document/servlet?action=show&zulnr=135697-P1&type=DOTC_FACH_INFO (2019). Accessed 11 May 2021.

5. The life and death of Helicobacter pylori;Scott D;Gut,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3